Holen Sie sich die Stockscreener-App
106.66
1.10%
1.16
Handel nachbörslich:
106.75
0.09
+0.08%
Schlusskurs vom Vortag:
$105.50
Offen:
$105.47
24-Stunden-Volumen:
7.77M
Relative Volume:
1.11
Marktkapitalisierung:
$158.04B
Einnahmen:
$18.49B
Nettoeinkommen (Verlust:
$2.50B
KGV:
63.49
EPS:
1.68
Netto-Cashflow:
$3.49B
1W Leistung:
+0.25%
1M Leistung:
+1.19%
6M Leistung:
+2.77%
1J Leistung:
+30.41%
1-Tages-Spanne:
$104.24
$106.87
1-Wochen-Bereich:
$104.24
$107.01
52-Wochen-Spanne:
$80.50
$108.53
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Sector ETF performance correlation with Boston Scientific Corporation2025 EndofYear Setup & AI Enhanced Execution Alerts - Newser
Analyzing drawdowns of Boston Scientific Corporation with statistical toolsOptions Play & High Win Rate Trade Alerts - Newser
Statistical indicators supporting Boston Scientific Corporation’s strengthShare Buyback & Weekly Watchlist for Consistent Profits - Newser
Boston Scientific reports strong Farapulse, Watchman FLX data - MassDevice
Boston Scientific Unit Defends Heart Valve Patent From Abbott - Law360
Risk adjusted return profile for Boston Scientific Corporation analyzed - Newser
Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer - GlobeNewswire Inc.
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results - Stock Titan
Can Boston Scientific Corporation navigate macro headwinds2025 EndofYear Setup & Weekly Return Optimization Plans - خودرو بانک
How high can Boston Scientific Corporation stock goStop Loss & Intraday High Probability Setup Alerts - Newser
Detecting price anomalies in Boston Scientific Corporation with AIJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
Using R and stats models for Boston Scientific Corporation forecasting2025 Analyst Calls & Real-Time Buy Zone Alerts - Newser
How sentiment analysis helps forecast Boston Scientific Corporation2025 Retail Activity & High Accuracy Trade Signal Alerts - Newser
What’s next for Boston Scientific Corporation stock priceJuly 2025 PreEarnings & Scalable Portfolio Growth Ideas - Newser
Stock Analysis | Boston Scientific OutlookA Technical Downturn Amid Mixed Analyst Signals - AInvest
Signal strength of Boston Scientific Corporation stock in tech scannersJuly 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Why is Boston Scientific Corporation stock going upJuly 2025 Spike Watch & Risk Controlled Swing Trade Alerts - خودرو بانک
Visual analytics tools that track Boston Scientific Corporation performance2025 Geopolitical Influence & Low Risk Entry Point Tips - Newser
Is a relief rally coming for Boston Scientific Corporation holdersJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
What moving averages say about Boston Scientific CorporationTrade Signal Summary & Daily Momentum Trading Reports - Newser
Does Boston Scientific Corporation show high probability of reboundJuly 2025 Highlights & Fast Entry High Yield Tips - Newser
Key resistance and support levels for Boston Scientific CorporationMarket Trend Summary & Verified Swing Trading Watchlists - Newser
Analyzing net buyer seller activity in Boston Scientific CorporationMarket Trend Review & Safe Capital Preservation Plans - Newser
What high frequency data says about Boston Scientific CorporationJuly 2025 Macro Moves & High Return Trade Opportunity Guides - Newser
Why Boston Scientific Corporation stock attracts strong analyst attentionJuly 2025 Update & Technical Pattern Alert System - Newser
Using Bollinger Bands to evaluate Boston Scientific Corporation2025 Retail Activity & Long-Term Growth Stock Strategies - Newser
Volume Surge May Signal Institutional Interest in Boston Scientific CorporationTrade Volume Report & Growth Focused Investment Plans - beatles.ru
Fund Flows: Can Boston Scientific Corporation navigate macro headwinds2025 Volatility Report & Consistent Income Trade Ideas - sundaytimes.kr
Combining price and volume data for Boston Scientific CorporationWatch List & Weekly Momentum Picks - Newser
Tools to monitor Boston Scientific Corporation recovery probabilityJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
Is Boston Scientific Corporation meeting your algorithmic filter criteriaJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Will Boston Scientific Corporation face regulatory challenges2025 Investor Takeaways & Comprehensive Market Scan Reports - sundaytimes.kr
What makes Boston Scientific Corporation stock price move sharplyEarnings Miss & Daily Technical Stock Forecast Reports - Newser
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):